OpenFilings
BridgeBio Pharma, Inc.
Form
8-K
Report Period
2025-06-20
Date Filed
2025-06-23
Time Filed
16:29:21
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
EXHIBIT 3.1
EXHIBIT 10.1
Filing on SEC Edgar